ABSTRACT
INTRODUCTION
The HIV/AIDS pandemic is continuously spreading at a rate of over 15,000 new infections every day. Heterosexual transmission is the leading mode of HIV-1 infection worldwide, with women particularly vulnerable (33). In the absence of an effective prophylactic anti-HIV therapy or vaccine, current efforts are aimed to developing anti-HIV agents such as retrovirucides or topical microbicide formulations. Accordingly, the World Health Organization has established a research priority for the development of effective anti-HIV vaginal microbicides (22) .
Substances that can be applied directly inside the vagina or the rectum before sexual intercourse to prevent the transmission of HIV and possibly other infections were proposed in 1990 and widely researched as one alternative to condoms (8, 29) . More than 60 candidate agents have already been identified to have in vitro activity against HIV, with six either in or about to enter Phase III efficacy trial testing (2) . More recently, rapid advances in our understanding of the biology of HIV transmission and infection have led to the development of microbicides that specifically target mechanisms of HIV transmission without harming the body's natural defenses (26) .
Potential retrovirucides or vaginal microbicides include inhibitors of HIV
surface glycoprotein and CD4 receptor interaction (3, 15, 17) , virus envelopedisrupting agents (18, 25), co-receptor antagonists (11, 12) , virus-cell fusion inhibitors (4) and viral uncoating inhibitors (7) . Inhibitors of reverse transcription, such as NNTRI, could also be potentially used as retrovirucides (30). Since their discovery, NNRTIs have become one of the cornerstones of highly active antiretroviral therapy (HAART). Currently, three NNRTI agents, efavirenz, nevirapine and delavirdine are commercially available (21) .
To screen for potential RT inhibitor compounds that fulfill the requirements for an effective microbicide a sensitive and high throughput assay would be useful. The NERT activity is based on intravirion DNA synthesis in the absence of permeabilizing agents. This has been termed natural ERT or NERT to distinguish it from the somewhat artificial process which takes place in standard ERT assays (36). NERT is made possible by the amphipathic domains of the gp41 transmembrane protein which render the HIV-1 envelope permeable to a range of small molecules such as dNTPs (37). NERT is an active process which is responsive to the virion microenvironment. Virions isolated from seminal plasma, which contains high levels of dNTPs, contained much higher levels of full-length or nearly full-length intravirion reverse transcripts than did virions isolated from the peripheral blood of the same patients (36). Moreover, the ability of purified virions to infect initially quiescent T cells and non-proliferating cells such as macrophages was significantly increased by pre-incubation of the virions with seminal plasma, indicating that NERT may be an integral part of the viral life cycle (36).
A C C E P T E D

METHODS AND MATERIALS
Plasmids. Plasmids encoding the HIV-1 genome were from the wild type pNL4-3 (1) and the mutant Z6gpt (32). The mutant Z6gptRT Y181C was obtained by introducing the Y181C mutation at the rt gene. This mutation is known to decrease the susceptibility of HIV-1 to the non-nucleoside analogue NVP (23).
The following primer were used in this site directed mutagenesis: (Reverse). All constructs were sequenced and checked by digestion map to confirm the presence of the desired mutation and plasmid integrity. Cell-free virions incubation with NNRTI. Supernatant of virus-producing cells were incubated for 2 h at 37°C with increasing concentrations of NNRTI in a final volume of 50µL of RPMI culture medium without FCS. Supernatants were divided into two identical aliquots. One aliquot was further submitted to NERT reaction followed by Real Time PCR to measure the minus-single stranded DNA (-ssDNA) production. The second aliquot was used to measure viral infectivity by HeLa-CD4-βGal assay.
A C C E P T E D
Drug retention in viruses exposed to NNRTI during budding. MT4 cells at a concentration of 2X10 6 cells/mL were infected by "spinnoculation" using 2X10 Cycling conditions were as follows: 50°C for 2 min, 95°C for 10 min, and 50 cycles at 95°C for 15 s and 60°C for 1 min. Z6gptRT wt proviral DNA was serially diluted on NERT stop solution and used to obtain Real Time-PCR standard curves (dilutions were from 10 7 to 10 1 copies of DNA and the detection limit of the assay was 10 initial template copies). Standard curves were used for the quantification of -ssDNA. At least two dilutions of each sample were assayed, and data sets in which the linear correlation coefficient of the standard curve was less than 0.98 were not included for further analysis. The 50% inhibitory concentration (IC 50 ) for each NNRTI, which is the concentration of NNRTI that is required for 50% reduction in RT activity (-ssDNA synthesis) relative to the non- 
RESULTS
NERT-based Real Time-PCR assay
It was demonstrated that without detergent the addition of dNTPs to isolated HIV-1 particles could stimulate intravirion RT activity leading to virions carrying -ssDNA intermediates and more-complete negative-strand molecules.
In our study intact virions were incubated with increasing concentrations of dNTPs at 37°C for 120 min and reactions were terminated by stop solution addition and boiling. -ssDNA products were quantified by Real-Time PCR amplifications using specific oligonucleotides and fluorescent probe ( Figure 1 ).
NERT reactions carried out without dNTPs addition did not produced appreciable levels of -ssDNA while the endogenous RT activity increased proportionally to the increase in dNTP concentration ( Moreover, the significant increment of permeability to dNTPs was observed only for the HIV-1 envelope glycoproteins, since the use of MLV envelope glycoproteins did not make pseudotyped virions more permeable to dNTPs as noted by the low -ssDNA synthesis levels found when the MLV-env pseudotyped virions was used in this experiment (Figure 2) . 
A C C E P T E D
Membrane permeability of virions and cells to NVP and EFV.
We evaluated the effects of NVP and EFV on -ssDNA synthesis by NERT based on Real-Time PCR quantification. These specific inhibitors of RT can bind directly to the hydrophobic pocket within the enzyme, causing a conformational change that disrupts the catalytic site and blocks its DNA polymerase activity (23) . Wild type virions obtained from Hek-293 transfections were exposed to increasing concentrations of NVP or EFV for 2 hours prior to NERT reactions. NERT was performed as described above and the synthesis of samples. The IC 50 was calculated for both NVP (Fig. 3A , dark circles) and EFV (Fig. 3B, dark circles) . NVP at 10 to 250 µM decreased total levels of -ssDNA from 75% and up to 98%, respectively (Fig. 3A) . This is in agreement with previous studies demonstrating NERT inhibition by NVP measured by radioactive semi-quantitative PCR (10). For EFV a concentration of 50 nM was effective in inhibiting NERT by 50% (Fig. 3B) .
In order to compare the permeability of NVP and EFV in cell-free with that of cell-associated viruses the aliquots of virions exposed to NVP and EFV were also tested for HeLa MAGI infection. We could observe that the IC 50 for NVP (Fig. 3A , open circles) and EFV (Fig. 3B, open effects of NNRTI inhibition in both viral infectivity and NERT assays demonstrating a good correlation between these two strategies. However, both NVP and EFV compounds were more effective in viral infectivity analyzed by HeLa MAGI cells than in -ssDNA synthesis evaluated by NERT reactions. In fact, the IC 50 values obtained for both NVP and EFV were significantly lower when measured by viral infectivity than for NERT reactions (Fig. 3A and 3B , open circles). The IC 50 values for cell-free viruses were demonstrated to be up to 100-fold higher for NVP and 10-fold higher for EFV than for HeLa MAGI cell infections ( Figures 3A and 3B ). These differences were statistically significant and suggest the effect of membrane composition on drug permeability. Since lower concentrations of both NVP and EFV were required to inhibit cellassociated than cell-free viruses, we conclude that cellular membranes could have higher permeability to NNRTI ingress when compared to viral membranes.
Effect of resistance mutations on NERT reaction on virions exposed to
NNRTI.
Using this system, we then tested the effect of NNRTIs on NERT reactions carried out in intact viral particles carrying the primary RT mutationY181C, which confers high levels of resistance to NVP (24) . The Y181C mutation was introduced by site directed mutagenesis into the Z6gpt infectious clone to generate the Z6gptRT Y181C mutant. Aliquots of both viruses Z6gpt and Z6gptRT Y181C were exposed to growing concentrations of NVP for 2 hours prior to NERT reactions. Synthesis of -ssDNA in the wild type virus was completely inhibited with a concentration of 6.5 µM of NVP, whereas, the Z6gptRT Y181C 
A C C E P T E D
Retention of NNRTIs into virions budded from infected cells in the presence of drugs.
A microbicide needs to be active against the first steps of virus replication cycle and to be incorporated into nascent virions during assembly and budding equally sensitive to the presence of NNRTI. Furthermore, this is the first time that the effect of a RT resistance mutation was demonstrated on a NERT assay.
We have also observed that a drug concentration over the IC 50 calculated in cells is required to inhibit NERT activity, and for the first time we could obtain an absolute quantification of this phenomena. The fold increase in drug concentration to completely inhibit NERT was dependent on the drug analyzed, up to 100-fold for NVP and 10-fold for EFV, however in both cases viral membrane composition can play an important role in virion permeability to antiretroviral drugs when compared to the infected cell situation.
Another important factor is the binding and retention of NNRTI drugs to the RT molecules inside viral particles budded in the presence of a RT inhibitor.
Typically, NNRTIs are hydrophobic molecules and readily traverse membrane barriers such as that surrounding the HIV core. However, this property would also facilitate the NNRTIs efflux from the virion in the absence of sufficient extra-virion levels of these inhibitors. In our experiments, we compared EFV and NVP retention inside the viral particle by dialysis procedures. NVP was easily washed off by the dialysis process when compared to EFV. The values of NERT inhibition for virus budded in the presence of EFV was not different after and before the wash off procedure suggesting that this NNRTI remains bound to the RT molecules inside the viral particles. These results agree with reports that named NNRTIs as rapid-equilibrium and tight-binding inhibitors (16) . NVP is a rapid-equilibrium inhibitor and requires an excess of this drug over the enzyme concentration (27) . On the other hand, EFV is a tight-binding inhibitor of inhibitors (31). EFV binds rapidly to RT, but once bound, dissociates only very slowly. Thus, RT remains inhibited for prolonged periods of time after binding, even in the absence of significant levels of unbound inhibitor or the wash off procedure to remove the excess of inhibitor (14) .Therefore, we suggested that tight-binding inhibition might be an important criterion for the NNRTI microbicide screening and compounds classified as tight-binding, such as EFV, have a great potential to be used as microbicides.
Although both NVP and EFV fulfill the basic requirements to be used as microbicide, our results for both the concentration required for NERT inhibition and the permeability to virions indicate that EFV is a potentially better candidate than NVP.
Of note, this is the first time that a highly sensitive methodology to 
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